Clinical trial
Targeted Interventions for Weight-Concerned Smokers
NCT00105482 · Yale University, Other · Completed
Key facts
| NCT number | NCT00105482 |
|---|---|
| Title | Targeted Interventions for Weight-Concerned Smokers |
| Official title | Testing the Effectiveness of Low Dose Naltrexone for Smoking Cessation and Minimization of Post-cessation Weight Gain |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nicotine Dependence |
| Intervention type | Behavioral, Drug |
| Interventions | Naltrexone, Transdermal nicotine replacement, Behavioral counseling |
| Enrollment | 172 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Mar 15, 2005 |
| Last update posted | Mar 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: